Background: Since the 2015 GRAPPA treatment recommendations were published, therapeutic options and management strategies for psoriatic arthritis (PsA) have advanced considerably. Objectives: The goal ...
1 Department of Rheumatology, René Descartes University, AP-HP, Cochin Hospital, Paris, France 2 Department of Rheumatology, General Hospital, Dijon University Hospital, Dijon, France 3 Laboratory of ...
Aims Treating to low disease activity is routine in rheumatoid arthritis, but no comparable goal has been defined for systemic lupus erythematosus (SLE). We sought to define and validate a Lupus Low ...
Background: Patient reported outcome measures used in studies of psoriatic arthritis (PsA) have been found to be inadequate for determining the impact of the disease from the patient’s perspective.
1 Division of Rheumatology, Department of Medicine, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, California, USA 2 MediQuest Therapeutics, Inc, Bothell, ...
1 Department of Clinical and Health Psychology, Utrecht University, Utrecht, The Netherlands 2 Department of Rheumatology and Clinical Immunology, University Medical Center Utrecht, Utrecht, The ...
1 Clinical Epidemiology Research and Training Unit, Department of Medicine, Boston University School of Medicine, Boston, Massachusetts, USA 2 Data Coordinating Center, Boston University School of ...
Correspondence to Professor Désirée van der Heijde, Department of Rheumatology, Leiden University Medical Center, PO Box 9600, Leiden 2300 RC, The Netherlands; mail{at}dvanderheijde.nl The overall ...
Objectives Alterations in the immune system and infections are suspected to increase susceptibility to giant cell arteritis (GCA). Recently herpes zoster has been directly implicated in the ...
13 National Institute of Health Research Manchester Musculoskeletal Biomedical Research Unit, Central Manchester University Hospitals NHS Foundation Trust, University of Manchester, Manchester, UK 14 ...
Adverse events of low- to medium-dose oral glucocorticoids in inflammatory diseases: a meta-analysis
1 University Medical Center Utrecht, Department of Rheumatology and Clinical Immunology, Utrecht, The Netherlands 2 University Medical Center Utrecht, Julius Centre for Health Sciences and Primary ...
The primary therapeutic target for rheumatoid arthritis is remission, assessed using validated composited measures.1 Currently, index-based remission frequently used in clinical practice are disease ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results